Table 2.
Changes in drug use during COVID-19 in cross-sectional online samples of people who use drugs in the Global Drug Survey (Winstock, et al., 2020) and the ADAPT Study (Sutherland, et al., 2020).
| Global Drug Survey (Global) | ADAPT (Australia) | |||||
|---|---|---|---|---|---|---|
| Decreased | No change | Increased | Decreased | No change | Increased | |
| Cannabis use | 21% | 38% | 40% | 15% | 29% | 57% |
| Alcohol use | 26% | 30% | 44% | 33% | 26% | 41% |
| Benzodiazepine use | 17% | 48% | 35% | 16% | 55% | 29% |
| Pharmaceutical opioid use | NA | NA | NA | 18% | 56% | 26% |
| Methamphetamine use | NA | NA | NA | 37% | 39% | 24% |
| Cocaine use | 39% | 41% | 20% | 45% | 39% | 16% |
| MDMA use | 42% | 46% | 13% | 49% | 36% | 15% |
| Heroin use | NA | NA | NA | 39% | 46% | 15% |